Iprivask side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Iprivask. Common side effects include dry eye among males.
The phase IV clinical study is created by eHealthMe based on 1 report from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1 person who takes Iprivask and has side effects is studied.
What is Iprivask?
Iprivask has active ingredients of desirudin recombinant. eHealthMe is studying from 1 Iprivask user for its effectiveness, alternative drugs and more.
Number of Iprivask reports submitted per year:
Iprivask side effects by gender *:
- Dry eye (lack of adequate tears)
Iprivask side effects by age (0-1 to 60+) *:
- Dry eye (lack of adequate tears)
* Approximation only. Some reports may have incomplete information.
Do you take Iprivask?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on desirudin recombinant (the active ingredients of Iprivask) and Iprivask (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Iprivask:
- Iprivask (1 reports)
All Iprivask side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cefobid and Dermatomyositis - now
- Piroxicam and Xopenex Hfa drug interaction - a second ago
- Paxil and Eye Irritation - a second ago
- Finasteride and Feeding Disorder - 2 seconds ago
- Apixaban and Loprox drug interaction - 12 seconds ago
- Nexium and Pseudotumor Cerebri - 13 seconds ago
- Carvedilol and Amrix drug interaction - 17 seconds ago
- Accupril and Cerebral Infarction - 17 seconds ago
- Amaryl and Cholangiolitis - 19 seconds ago
- Mycostatin and Sepsis - 25 seconds ago